International markets update:
Investors face a complex landscape marked by new tariff threats, significant developments in the AI sector, and heightened geopolitical tensions. This dynamic environment precedes a crucial earnings day, featuring reports from major Wall Street players.
- Former President Trump’s proposal to raise tariffs on generic drugs to 100% by 2028 and 200% thereafter targets reshoring pharmaceutical production, a move with significant implications for major suppliers like India.
- The U.S. and China are set for AI talks in September, while the Trump administration will investigate whether Chinese AI models are derived from American ones, signaling potential intellectual property enforcement.
- Samsung is reportedly considering a 1 billion euro investment in French AI darling Mistral, which could value the startup at approximately 20 billion euros, highlighting the ongoing high valuations and strategic investments in the AI space.
- U.S. Secretary of State Marco Rubio indicated Iran is not serious about peace talks, as American forces conducted an 11th consecutive night of strikes in Iran, aiming to degrade its ability to threaten shipping in the Strait of Hormuz.
- Wall Street is preparing for major post-bell earnings reports from tech giants Alphabet and Tesla, with options traders anticipating Tesla could experience its largest post-earnings stock movement in a year.
- Unexpected AI beneficiaries like Japanese companies Toto, Nittobo, and Ajinomoto, specializing in toilets, glass fiber, and seasonings respectively, have seen significant share gains by leveraging their core technologies within the AI supply chain.
Stock Market News summarised for the Wall Street Investors Club community.